| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |